Ben Corn graduated the accelerated BA/MD track at Boston University. He trained in Oncology at University of Pennsylvania where he was appointed Assistant Professor. He moved to Fox Chase Cancer Center as an Associate Member. Subsequently, he was Vice Chairman and Full Professor of Radiation Oncology at Jefferson Medical College before emigrating from the USA. Upon landing in Israel, he was infected by “start-up nation” and became CEO of Keryx which he led to IPO on NASDAQ.
In 2003, he was appointed Chairman of Radiotherapy at Tel Aviv Medical Center. He has served as Chairman of the CNS Committee of the RTOG and his diverse research includes integrating radiotherapy and chemotherapy for glioblastoma, and protection of the hippocampus in the setting of brain metastases. He has authored 250 articles in the medical literature (including publications in New England Journal of Medicine, JAMA, Lancet) and 100 essays in the popular literature (including the Wall Street Journal, St Louis Post-Dispatch and The Atlantic. ) He is currently Interim Director of the Cancer Center at SZMC in Jerusalem.
In 2003, Ben co-founded (with Dvora Corn) the NGO, Life’s Door. The organization has offered workshops to over 10,000 cancer patients who are in need of coping tools (rarely provided by the Israeli healthcare system). For these efforts, he was awarded the Citation for Volunteerism by President Shimon Peres in 2012 and the Builders of Zion prize in 2017. He became a Fellow of the American Society of Radiation Oncology (F.A.S.T.R.O.) in 2018
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none